One drinking water recall issued earlier this year by the U.S. Food and Drug Administration was terminated last week.
The FDA is set to give its decision on SNY and REGN's sBLA for Dupixent for chronic spontaneous urticaria on April 18, 2025.
Pharmacies that make customized medications are asking the federal Food and Drug Administration to protect their right to ...
A Vitamin B supplement has been recalled due to being incorrectly formulated with niacin rather than niacinamide.
The U.S. patient population for Revuforj in its approved indication is roughly 2,000 according to Syndax. KMT2A leukemias ...
The US Food and Drug Administration (FDA) has approved Syndax Pharmaceuticals' Revuforj (revumenib) for treating relapsed or ...
Think Surgical announced today that it received FDA 510(k) clearance to use its TMINI surgical robot with the LinkSymphoKnee.
The FDA-cleared Spectral CT 7500 RT, a detector-based computed tomography radiotherapy solution aimed to enhance radiation ...
The recent approval of their lead asset, Aucatzyl, by the FDA is seen as a pivotal factor in de-risking the company’s technology platform and manufacturing capabilities. The differentiated safety ...
BrightHeart announced that it received FDA 510(k) clearance for its first AI software for prenatal ultrasound evaluations of ...